RecruitingNot ApplicableNCT06573320

Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients Treated With Clozapine

Investigating the Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients Treated With Clozapine

Sponsor

Dr. Lutfi Kirdar Kartal Training and Research Hospital

Enrollment

60 participants

Start Date

Mar 14, 2024

Study Type

INTERVENTIONAL

Conditions

Exercise Schizophrenia Clozapine

Summary

This prospective study aims to investigate the effects of exercise on clinical symptoms, cognitive performance, and quality of life in schizophrenia patients treated with Clozapine.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study looks at whether adding a structured exercise program improves symptoms, thinking, and quality of life in people with schizophrenia who are being treated with clozapine (a medication used for treatment-resistant schizophrenia). **You may be eligible if...** - You have been diagnosed with schizophrenia by a psychiatrist - You are currently taking clozapine at a dose between 300 and 500 mg per day - You are being treated at the Kartal Dr. Lütfi Kırdar City Hospital in Turkey **You may NOT be eligible if...** - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.